Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older (Q47547115): Difference between revisions

From Wikidata
Jump to navigation Jump to search
KlaudiuBot (talk | contribs)
Removed claim: author name string (P2093): Simona Bataga
KlaudiuBot (talk | contribs)
Removed claim: author name string (P2093): Carmen Preda
Property / author name string
Carmen Preda
 
Property / author name string: Carmen Preda / rank
Normal rank
 
Property / author name string: Carmen Preda / qualifier
 
Property / author name string: Carmen Preda / reference
stated in: Europe PubMed Central
PMC publication ID: 5815789
retrieved: 4 March 2018
Timestamp+2018-03-04T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

reference URL: http://europepmc.org/abstract/PMC/5815789
 

Revision as of 16:34, 27 August 2024

scientific article published in December 2017
Language Label Description Also known as
English
Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older
scientific article published in December 2017

    Statements

    Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older (English)

    Identifiers